Expression of ATG5 (p < 0.001; Figures 6A,B) and ATG12 (p < 0.001; Figures 6A,B) were markedly decreased in the AD group compared with that of the WT group, which were protected by DHA treatment. The gene discussed is ATG12; the disease is Alzheimer disease.